...
首页> 外文期刊>Drug delivery letters >Paroxetine Hydrochloride Push-pull Osmotic Pump Tablets: Designing an Innovative, Scalable Push-pull Osmotic Drug Delivery System Using QbD Approach
【24h】

Paroxetine Hydrochloride Push-pull Osmotic Pump Tablets: Designing an Innovative, Scalable Push-pull Osmotic Drug Delivery System Using QbD Approach

机译:盐酸盐水推拉渗透泵片剂:使用QBD方法设计创新,可伸缩的推拉渗透药物递送系统

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Paroxetine hydrochloride hemihydrate (PHH) is a serotonin reuptake inhibitoruseful for the treatment of diverse psychiatric problems. Existing marketed formulations with frequentadministration lead to gastrointestinal (GI) reactions and abrupt fluctuations in plasma level with poorpatient compliance. These prerequisites are sufficed by controlled release push-pull osmotic pump tablets(PPOP).Objective: Objective of the present study was to develop robust and reliable PPOP formulation viaQuality by design (QbD) approach to achieve desired release kinetics.Methods: PPOP was formulated using wet granulation method followed by osmotic coating. QbDstrategy for defining the risk assessment of influential variables such as swelling polymers andosmogen on in vitro release kinetics of designed PPOP.Results: Presence of Polyox in push and pull layer along with osmogen controlled the drug releasepattern from formulated PPOP system as depicted in 33 factorial design. These formulated optimizedPPOP systems demonstrated 2 hrs lag time with zero-order kinetics, a peculiar feature of PPOPs.Conclusion: Scalable, stable PPOP tablets were fabricated by applying systematic QbD approach. Thedeveloped PPOP systems with improved concentration-independent behavior helped to address thechallenges of existing marketed formulations. Risk mitigation and control strategy assured quality ofthe system during scalability. Application of QbD strategy in establishing the PPOP formulation wouldhelp in formulating drug candidates having gastric limitations and poor patient compliance. The presentstudy is the detailed account of QbD based PPOP formulation, therefore it can be of potential importancefrom academics as well as industrial perspective.
机译:背景:盐酸盐氨氨酸半水合物(PHH)是一种血清素再摄取抑制作用,用于治疗各种精神病问题。现有的繁体发行制剂具有嗜胃(GI)反应,血浆水平突然波动与差异不良。这些先决条件是由控制释放推拉渗透泵片剂(PPOP)足够的。目的:目前的目的是通过设计(QBD)方法制定鲁棒性和可靠的PPOP配方稳定性,以实现所需的释放动力学。方法:PPOP被制定使用湿造粒方法,然后用渗透涂层。 QBDStrategy用于定义有影响的变量的风险评估,例如在体外释放的设计PPOP的体外释放动力学上的溶胀聚合物和渗透剂。结果:Polyox在推动和拉伸层中的存在以及锻造的PPOP系统中的药物储物术,如33个因素设计所示。这些配制的优化PPOP系统展示了2小时滞后时间,具有零级动力学,PPOPS的特殊特征。结论:通过施加系统QBD方法来制造可扩展的,稳定的PPOP片剂。具有改进的集中行为的PPOP系统有助于解决现有销售制剂的TheChallenges。风险缓解和控制策略在可扩展性期间保证系统的质量。 QBD策略在制定胃局限性患者患者患者患者患者中的PPOP制剂的应用及患者依从性。 ThementStudy是基于QBD的PPOP制剂的详细描述,因此它可能具有来自学者的潜在的重要性以及工业角度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号